Attachment A -- Supplemental Evidence and Data for Systematic Reviews Request Letter

Attachment A -- Opportunity to Submit Scientific Information E-mail

From: Agency for Healthcare Research and Quality (AHRQ)
Sent: Thursday, March 10, 2022 5:23 PM
To: Benns, Jenae (AHRQ/CEPI)
Subject: EHC Program Update: Protocol on Postpartum Management of Women who Experience
Hypertensive Disorders of Pregnancy Now Available

Opportunity to Submit Scientific Information
The Ef f ective Health Care (EHC) Program is interested in receiving supplemental evidence and
data (SEADs) f or systematic reviews that are relevant to the questions in our evidence reports. To
ensure that it has f ull access to relevant research, whether or not it is published, the EHC Program
is interested in receiving SEADs containing detailed study-specific inf ormation. Opportunities to
submit scientif ic information are available f or:
Postpartum Home Blood Pressure Monitoring, Postpartum Treatment of Hypertensive Disorders
of Pregnancy, and Peripartum Magnesium Sulf ate Regimens f or Preeclampsia With Severe
Features
(Available f or submission until April 1, 2022)
The purpose of the review is to summarize the f indings from (1) studies of home BP monitoring in
the postpartum period, (2) studies of pharmacological treatment of HDP in the postpartum period,
and (3) studies comparing the ef f ectiveness and harms of different MgSO4 regimens in patients
with preeclampsia with severe f eatures to prevent eclampsia during the peripartum period. For the
third topic, the peripartum period is operationally defined as the time interval prior to, during, or
af ter delivery when individuals may be diagnosed with preeclampsia with severe f eatures. For all
topics, the review will summarize f indings related to differences in treatment ef f ectiveness (and
harms) in dif f erent populations, with an emphasis, as f easible, on f actors related to healthcare
disparities and pregnancy-related risk f actors.

(Section 944 (c) of the Public Health Service Act [42 U.S.C. 299c 3(c)] requires that information
collected for research conducted or supported by AHRQ that identifies individuals or
establishments be used only for the purpose for which it was supplied unless they consent to the
use of the information for another purpose.)

About us: AHRQ’s Effective Health Care Program is committed to providing the best available
evidence on the outcomes, benefits and harms, and appropriateness of drugs, devices, and health
care services and by helping health care professionals, patients, policymakers, and health care
systems make informed health care decisions. The program partners with research centers,
academic institutions, health professional societies, consumer organizations, and other
stakeholders to conduct research, evidence synthesis, evidence translation, dissemination, and
implementation of research findings.
To learn more: https://effectivehealthcare.ahrq.gov/
Contact us at [email protected]